Advanced Code injection
0
Skip to Content
OBIO - Ontario Bioscience Innovation Organization
About OBIO
Governance
OBIO Team
Our Partners
Contact Us
At a Glance
Capital Access & Adoption
Skills Development & Training
Women in Health Initiative
Critical Technologies
Advocacy Efforts
All Events
OBIO Investment Summit
News & Press Releases
Tariff Relief Resources
Membership
Member Log in
Job Board
OBIO - Ontario Bioscience Innovation Organization
About OBIO
Governance
OBIO Team
Our Partners
Contact Us
At a Glance
Capital Access & Adoption
Skills Development & Training
Women in Health Initiative
Critical Technologies
Advocacy Efforts
All Events
OBIO Investment Summit
News & Press Releases
Tariff Relief Resources
Membership
Member Log in
Job Board
Folder: About
Back
About OBIO
Governance
OBIO Team
Our Partners
Contact Us
Folder: Areas of Focus
Back
At a Glance
Capital Access & Adoption
Skills Development & Training
Women in Health Initiative
Critical Technologies
Advocacy Efforts
Folder: Events
Back
All Events
OBIO Investment Summit
Folder: News
Back
News & Press Releases
Tariff Relief Resources
Folder: Membership
Back
Membership
Member Log in
Job Board
OBIO News, Ontario Industry Updates Arsheen Kaur 11/8/23 OBIO News, Ontario Industry Updates Arsheen Kaur 11/8/23

Ontario biotech start-ups get government funding boost

Read More
OBIO News, Ontario Industry Updates Arsheen Kaur 11/8/23 OBIO News, Ontario Industry Updates Arsheen Kaur 11/8/23

Northern Nanopore Instruments acquired by Oxford Nanopore Technologies

Read More
OBIO News, Ontario Industry Updates Arsheen Kaur 11/8/23 OBIO News, Ontario Industry Updates Arsheen Kaur 11/8/23

Enhanced Medical Nutrition over-subscribes pre-series A financing, announces strategic investment from dsm-firmenich

Read More
OBIO News, Ontario Industry Updates Arsheen Kaur 11/8/23 OBIO News, Ontario Industry Updates Arsheen Kaur 11/8/23

Edesa Biotech to receive up to CAD $23 Million in funding from Federal Government

Read More
OBIO News, Ontario Industry Updates Arsheen Kaur 10/25/23 OBIO News, Ontario Industry Updates Arsheen Kaur 10/25/23

Specific Biologics announces additional investment and appointment of experienced biotechnology leader to the Board of Directors

Read More
OBIO News, Ontario Industry Updates Arsheen Kaur 10/25/23 OBIO News, Ontario Industry Updates Arsheen Kaur 10/25/23

Ironstone Product Development (IPD) acquired by global medtech leader, Avania

Read More
OBIO News, Ontario Industry Updates Arsheen Kaur 10/25/23 OBIO News, Ontario Industry Updates Arsheen Kaur 10/25/23

Innovation Factory expands support for high-potential life science innovators by introducing medtech manufacturing funding program

Read More
OBIO News, Ontario Industry Updates Arsheen Kaur 10/25/23 OBIO News, Ontario Industry Updates Arsheen Kaur 10/25/23

Flosonics Medical among HeartX Accelerator’s selected companies for the 2023 program

Read More
OBIO News, Ontario Industry Updates Arsheen Kaur 10/11/23 OBIO News, Ontario Industry Updates Arsheen Kaur 10/11/23

AI at the bedside: First-ever Extubation Decision Support Product approved in Canada

Read More
OBIO News, Ontario Industry Updates Arsheen Kaur 10/11/23 OBIO News, Ontario Industry Updates Arsheen Kaur 10/11/23

FluidAI Medical announces $15M in Series A funding for AI-driven postoperative monitor at HLTH 2023

Read More
OBIO News, Ontario Industry Updates Arsheen Kaur 10/11/23 OBIO News, Ontario Industry Updates Arsheen Kaur 10/11/23

Conavi Medical announces closing of financing to bolster novel intravascular imaging technology

Read More
OBIO News, Ontario Industry Updates Arsheen Kaur 10/11/23 OBIO News, Ontario Industry Updates Arsheen Kaur 10/11/23

Allarta receives award from JDRF to advance its work in creating a functional cure for type 1 diabetes

Read More
OBIO News, Ontario Industry Updates Arsheen Kaur 9/26/23 OBIO News, Ontario Industry Updates Arsheen Kaur 9/26/23

Zucara Therapeutics doses first patient in Phase 2a ‘ZONE’ trial

Read More
OBIO News, Ontario Industry Updates Arsheen Kaur 9/26/23 OBIO News, Ontario Industry Updates Arsheen Kaur 9/26/23

Paradox Immunotherapeutics is BIO’s emerging Start-Up Stadium winner

Read More
OBIO News, Ontario Industry Updates Arsheen Kaur 9/26/23 OBIO News, Ontario Industry Updates Arsheen Kaur 9/26/23

Ontario Brain Institute announces $600,000 in funding to the NERVE cohort

Read More
OBIO News, Ontario Industry Updates Arsheen Kaur 9/13/23 OBIO News, Ontario Industry Updates Arsheen Kaur 9/13/23

Retispec’s eye test tool could catch Alzheimer’s signs years earlier

Read More
OBIO News, Ontario Industry Updates Arsheen Kaur 9/13/23 OBIO News, Ontario Industry Updates Arsheen Kaur 9/13/23

HDAX Therapeutics’ co-founder announced winner of 2023 Gold Leaf Awards for Next Generation Leadership

Read More
OBIO News, Ontario Industry Updates Arsheen Kaur 9/13/23 OBIO News, Ontario Industry Updates Arsheen Kaur 9/13/23

Epineuron announces enrollment of its first patient in REGAIN™

Read More
OBIO News, Ontario Industry Updates Arsheen Kaur 8/29/23 OBIO News, Ontario Industry Updates Arsheen Kaur 8/29/23

Liberum raises $1.8 million for ‘protein synthesis as a service’

Read More
OBIO News, Ontario Industry Updates Arsheen Kaur 8/29/23 OBIO News, Ontario Industry Updates Arsheen Kaur 8/29/23

Empower Health among 12 companies in the cohort of artificial intelligence ventures solving supply chain challenges

Read More
Newer Posts
Older Posts
Become an OBIO® Member Today!

Contact us:

OBIO®
101 College St., Suite HL50

Toronto, ON M5G 1L7

OBIO © 2025

(416) 848 6839
info@obio.ca

Media Kit

NEWSlETTER Sign UP

Terms & Conditions